Tamoxifen for amyotrophic lateral sclerosis: A randomized double-blind clinical trial.

Medicine (Baltimore) · 2020 · PMC12245230 · PMID 32481440

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The proportion of participants reaching the primary end point was lower in the tamoxifen group but did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.